Antibodies in myasthenia gravis and related disorders

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 324-335

  Vincent, Angela ^a   McConville, John ^a   Farrugia, Maria Elena ^a   Bowen, John ^a   Plested, Paul ^a   Tang, Teresa ^a   Evoli, Amelia ^b   Matthews, Ian ^a   Sims, Gary ^c   Dalton, Paola ^a   Jacobson, Leslie ^a   Polizzi, Agata ^a   Blaes, Frans ^a   Lang, Bethan ^a   Beeson, David ^a   Willcox, Nick ^a   Newsom Davis, John ^a   Hoch, Werner ^d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CATHOLIC UNIVERSITY   (Italy)

^c WESTERN INFIRMARY   (United Kingdom)

^d University of Houston   (United States)

Author keywords

Adult acetylcholine receptor; Arthrogryposis multiplex congenita; Disease severity; Fetal acetylcholine receptor; Muscle atrophy; Muscle specific kinase; MuSK; Myasthenia gravis; Seronegative myasthenia

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MUSCLE SPECIFIC KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTHROGRYPOSIS; CONFERENCE PAPER; HUMAN; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKING; NONHUMAN; ONSET AGE; PLACENTAL TRANSFER; PREGNANCY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RADIOIMMUNOPRECIPITATION; STILLBIRTH;

EID: 0141504314     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.036     Document Type: Conference Paper

References (33)

1. GOTTI, C. et al. 1997. Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay. Muscle Nerve 20: 800-808.
2. RICNY, J., L. SIMKOVA & A. VINCENT. 2002. Determination of anti-acetylcholine receptor antibodies in myasthenic patients by use of time-resolved fluorescence. Clin. Chem. 48: 549-554.
3. FOSTIERI, E., D. BEESON & S.J. TZARTOS. 2000. The conformation of the main immunogenic region on the alpha-subunit of muscle acetylcholine receptor is affected by neighboring receptor subunits. FEBS Lett. 481: 127-130.
4. ALEXEEV, T. et al. 1999. Physicochemical and immunological studies of the N-terminal domain of the Torpedo acetylcholine receptor alpha-subunit expressed in Escherichia coli. Eur. J. Biochem. 259: 310-319.
5. PSARIDI-LINARDAKI, L. et al. 2002. Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris: role of glycosylation in alpha-bungarotoxin binding. J. Biol. Chem. 277: 26980-26986.
6. VINCENT, A. et al. 1995. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 346: 24-25.
7. RIEMERSMA, S. et al. 1996. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J. Clin. Invest. 98: 2358-2363.
8. BRUETON, L.A. et al. 2000. Asymptomatic maternal myasthenia as a cause of the Pena-Shokeir phenotype. Am. J. Med. Genet. 92: 1-6.
9. JACOBSON, L. et al. 1999. An animal model of antibody-mediated neurodevelopmental disease: arthrogryposis multiplex congenita caused by antibodies to fetal acetylcholine receptor. J. Clin. Invest, 103: 1031-1038.
10. FARRAR, J. et al. 1997. Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. Int. Immunol. 9: 1311-1318.
11. MATTHEWS, I., G. SIMS et al. 2002. Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen. Lab. Invest. 82: 1407-1417.
12. GRAUS, Y.F. et al. 1997. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. J. Immunol. 158: 1919-1929.
13. SCHLUEP, M. et al. 1987. Acetylcholine receptors in human myoid cells in situ: an immunohistological study. Ann. Neurol. 22: 212-222.
14. BEESON, D. et al. 1996. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology 47: 1552-1555.
15. MACLENNAN, C. et al. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann. Neurol. 41: 423-431.
16. WINTZEN, A.R. et al. 1998. Acquired slow channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel. Ann. Neurol. 44: 657-664.
17. SCHON, F., M. DRAYSON & R.A. THOMPSON. 1996. Myasthenia gravis and elderly people. Age Ageing 25: 56-58.
18. SOMNIER, F.E. 1996. Myasthenia gravis. Dan. Med. Bull. 43: 1-10.
19. ROMI, F. et al. 2000. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Arch. Neurol. 57: 1596-1600.
20. MEAGER, A. et al. 1997. Spontaneous neutralising antibodies to interferon-α and interleukin-12 in thymoma-associated autoimmune disease. Lancet 350: 1596-1597.
21. BUCKLEY, C. et al. 2001. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence? Neurology 57: 1579-1582.
22. MOSSMAN, S., A. VINCENT & J. NEWSOM-DAVIS. 1986. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet i: 116-118.
23. EVOLI, A. et al. 1996. Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscul. Disord. 6: 155-161.
24. BURGES, J. et al. 1990. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro. Muscle Nerve 13: 407-413.
25. YAMAMOTO, T. et al. 1991. Seronegative myasthenia gravis: a plasma factor inhibiting agonist induced acetylcholine receptor function co-purifies with IgM. Ann. Neurol. 30: 550-557.
26. PLESTED, C.P. et al. 2002. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG. Neurology 59: 1682-1688.
27. PLESTED, C.P., J. NEWSOM-DAVIS & A. VINCENT. 1998. Seronegative myasthenia plasmas and non-IgG fractions transiently inhibit nAChR function. Ann. N.Y. Acad. Sci. 841: 501-504.
28. MIER, A.K. & C.W.H. HAVARD. 1985. Diaphragmatic myasthenia in mother and child. Postgrad. Med. J. 61: 725-727.
29. BLAES, F. et al. 2000. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor. Ann. Neurol. 47: 504-510.
30. HOCH, W. 1999. Formation of the neuromuscular junction: agrin and its unusual receptors. Eur. J. Biochem. 265: 1-10.
31. LIYANAGE, Y. et al. 2001. The agrin/muscle specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 25: 4-16.
32. HOCH, W. et al. 2001. Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7: 365-368.
33. ENGEL, A.G. & K. ARAHATA. 1987. The membrane attack complex of complement at the endplate in myasthenia gravis. Ann. N.Y. Acad. Sci. 505: 326-332.